QIAcuity Digital PCR System
For nanoplate-based digital PCR applications
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
- Fully integrated system
- Scalable format (1-, 4- and 8-plate instruments)
- Advanced multiplexing capabilities (up to 5 plex)
- Flexible sample throughput
- Comprehensive results in approx. 2 hours
The QIAcuity Digital PCR System is designed to deliver precise and multiplexed quantification results for mutation detection, copy number variation (CNV), gene expression studies, gene-editing analysis, and many more. This nanoplate-based system seamlessly integrates a standard dPCR workflow of partitioning, thermocycling and imaging into a walk-away automated platform with minimal hands-on time.
The system is used in conjunction with the QIAcuity nanoplates, reagents and assays.
QIAGEN expands portfolio for minimal residual disease testing in oncology with new strategic partnerships
Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of MRD capabilities, especially using QIAcuity digital PCR
QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology
QIAcuityDx provides highly precise, absolute quantitation of target DNA and RNA, making it an ideal tool for monitoring cancer progression
Scientists tackle the threat of invasive fungal disease with cutting-edge diagnostics
With the QIAGEN nanoplate-based dPCR system, clinical scientists find better ways to diagnose invasive fungal disease and side-step antifungal therapy resistance
Predictive molecular pathology: Improving clinical outcomes for cancer patients
Prof. Umberto Malapelle, Chair of Predictive Molecular Pathology Laboratory and Scientific Secretary of the International Society of Liquid Biopsy shares insights on how predictive molecular pathology could improve targeted therapies and personalized care
